Literature DB >> 15973022

Benign acute childhood myositis.

Sarala Rajajee1, S Ezhilarasi, K Rajarajan.   

Abstract

OBJECTIVE: To describe the clinical and laboratory features of benign acute childhood myositis.
METHODS: 40 children of BACM were seen during October 2001 to February 2002, 22 (52%) were male with mean age of 5.3 years. Duration of illness was 3.97 days. Preceding symptoms included fever, leg pain, vomiting and inability to walk. A provisional diagnosis of viral myositis was made in 26 (66%). Guillian Barre Syndrome was the most common referral diagnosis.
RESULTS: 11 (27.5%) children had leucopenia with lymphocytic response and 16 (40%) had thrombocytopenia. CRP was negative in 32 (80%). CPK was markedly elevated (more than 1000 IU/l) in 18 (45%) and more than 500 IU/l in 11 (27.5%) remaining between 200 to 500 IU/l. Associated features were hepatitis (elevated SGOT & SGPT) in 28 (70%) and shock in 5 (12.5%). Serological test were indicative of dengue virus (Elisa PAN BIO) in 20 (50%) of which 8 (25%) were primary dengue and 12 (30%) were secondary dengue. The outcome of therapy mainly supportive were excellent.
CONCLUSION: Benign acute myositis occurs often in association with viral infection. In the present study, Dengue virus was positive in 20 (50%) children. Benign acute myositis can be differentiated from more serious causes of walking difficulty by presence of calf and thigh muscle tenderness on stretching, normal power and deep tendon reflex and elevated CPK.

Entities:  

Mesh:

Year:  2005        PMID: 15973022     DOI: 10.1007/BF02731735

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  4 in total

1.  Myalgia cruris epidemica.

Authors:  A LUNDBERG
Journal:  Acta Paediatr       Date:  1957-01       Impact factor: 2.299

2.  Transient acute myositis in childhood.

Authors:  I A McKinlay; I Mitchell
Journal:  Arch Dis Child       Date:  1976-02       Impact factor: 3.791

3.  Severe myositis during recovery from influenza.

Authors:  P J Middleton; R M Alexander; M T Szymanski
Journal:  Lancet       Date:  1970-09-12       Impact factor: 79.321

4.  Benign acute childhood myositis.

Authors:  J H Antony; P G Procopis; R A Ouvrier
Journal:  Neurology       Date:  1979-07       Impact factor: 9.910

  4 in total
  8 in total

1.  SHP-1-dependent macrophage differentiation exacerbates virus-induced myositis.

Authors:  Neva B Watson; Karin M Schneider; Paul T Massa
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

2.  Post streptococcal myalgia: an under-recognized clinical syndrome.

Authors:  Thirunavukkarasu Arun Babu; Chandrasekaran Venkatesh
Journal:  Indian J Pediatr       Date:  2011-06-22       Impact factor: 1.967

3.  Benign acute childhood myositis complicating influenza B infection in a boy with idiopathic nephrotic syndrome.

Authors:  Piotr Skrzypczyk; Joanna Przychodzień; Małgorzata Pańczyk-Tomaszewska
Journal:  Cent Eur J Immunol       Date:  2016-10-25       Impact factor: 2.085

4.  A study of acute muscle dysfunction with particular reference to dengue myopathy.

Authors:  Rajesh Verma; Vikram V Holla; Vijay Kumar; Amita Jain; Nuzhat Husain; Kiran Preet Malhotra; Ravindra Kumar Garg; Hardeep Singh Malhotra; Praveen Kumar Sharma; Neeraj Kumar
Journal:  Ann Indian Acad Neurol       Date:  2017 Jan-Mar       Impact factor: 1.383

5.  Benign Acute Childhood Myositis: A Benign Disease that Mimics More Severe Neuromuscular Disorder.

Authors:  Sunil Pradhan; Animesh Das; Sucharita Anand
Journal:  J Pediatr Neurosci       Date:  2018 Oct-Dec

Review 6.  Neurological Complications of Dengue Fever.

Authors:  Sweety Trivedi; Ambar Chakravarty
Journal:  Curr Neurol Neurosci Rep       Date:  2022-06-21       Impact factor: 6.030

7.  Dengue: a new challenge for neurology.

Authors:  Marzia Puccioni-Sohler; Marco Orsini; Cristiane N Soares
Journal:  Neurol Int       Date:  2012-11-13

Review 8.  Neurological Manifestations of Dengue Infection.

Authors:  Guo-Hong Li; Zhi-Jie Ning; Yi-Ming Liu; Xiao-Hong Li
Journal:  Front Cell Infect Microbiol       Date:  2017-10-25       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.